Cargando…

Effectiveness of interferon-beta and temozolomide combination therapy against temozolomide-refractory recurrent anaplastic astrocytoma

BACKGROUND: Malignant gliomas recur even after extensive surgery and chemo-radiotherapy. Although a relatively novel chemotherapeutic agent, temozolomide (TMZ), has demonstrated promising activity against recurrent glioma, the effects last only a few months and drug resistance develops thereafter in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujimaki, Takamitsu, Ishii, Hisato, Matsuno, Akira, Arai, Hajime, Nakagomi, Tadayoshi
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976115/ https://www.ncbi.nlm.nih.gov/pubmed/17683572 http://dx.doi.org/10.1186/1477-7819-5-89

Ejemplares similares

Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
por: Gwak, Ho-Shin, et al.
Publicado: (2013)

Combination Therapy with Rituximab and Temozolomide for Recurrent and Refractory Primary Central Nervous System Lymphoma
por: Murakami, Mineko, et al.
Publicado: (2011)

Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and effectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma
por: Sarica, Feyzi Birol, et al.
Publicado: (2012)

Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide
por: Khaddour, Karam, et al.
Publicado: (2020)

Anaplastic astrocytoma cells not detectable on autopsy following long-term temozolomide treatment: A case report
por: Hirano, Hirofumi, et al.
Publicado: (2017)

Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era
por: Paravati, Anthony J., et al.
Publicado: (2010)

Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas
por: Omar, Ayman I, et al.
Publicado: (2010)

Podocalyxin regulates astrocytoma cell invasion and survival against temozolomide
por: WU, HAO, et al.
Publicado: (2013)

Complete Radiologic Response in an Anaplastic Oligodendroglioma Treated with Temozolomide and Bevacizumab
por: Katz, Artur, et al.
Publicado: (2009)

Temozolomide and cisplatin in relapsed/refractory acute leukemia
por: Seiter, Karen, et al.
Publicado: (2009)

Response of Leptomeningeal Dissemination of Anaplastic Glioma to Temozolomide: Experience of Two Cases
por: Bae, Jin Woo, et al.
Publicado: (2017)

Radiation combined with temozolomide contraindicated for young adults diagnosed with anaplastic glioma
por: Yang, Pei, et al.
Publicado: (2016)

Extended-schedule dose-dense temozolomide in refractory gliomas
por: Berrocal, A., et al.
Publicado: (2009)

Vincristine, Irinotecan, and Temozolomide in Patients With Relapsed/Refractory Neuroblastoma
por: Zhu, Jia, et al.
Publicado: (2022)

Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas
por: Holdhoff, Matthias, et al.
Publicado: (2023)

Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
por: Weller, Jonathan, et al.
Publicado: (2022)

Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas
por: Yang, Seung-Ho, et al.
Publicado: (2006)

Modulated Radiotherapy with Concurrent and Adjuvant Temozolomide for Anaplastic Gliomas: Indian Single-center Data
por: Kataria, Tejinder, et al.
Publicado: (2017)

Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells
por: Feldheim, Jonas, et al.
Publicado: (2022)

Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma
por: Osman, Mohammed A
Publicado: (2014)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

Temozolomide-Induced Myelodysplasia
por: Natelson, Ethan A., et al.
Publicado: (2010)

Case Report: Temozolomide Treatment of Refractory Prolactinoma Resistant to Dopamine Agonists
por: Tang, Hao, et al.
Publicado: (2021)

JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma
por: Wakabayashi, Toshihiko, et al.
Publicado: (2018)

The genetic landscape of anaplastic astrocytoma
por: Killela, Patrick J., et al.
Publicado: (2013)

Combination Therapy for Gliomas Using Temozolomide and Interferon-Beta Secreting Human Bone Marrow Derived Mesenchymal Stem Cells
por: Park, Jae-Hyun, et al.
Publicado: (2015)

Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients
por: Wang, Yu, et al.
Publicado: (2017)

Temozolomide and oral etoposide in children with recurrent malignant brain tumors
por: Ruggiero, Antonio, et al.
Publicado: (2020)

Apatinib Plus Temozolomide: An Effective Salvage Treatment for Recurrent Glioblastoma
por: Ge, Jingjing, et al.
Publicado: (2021)

Apatinib and temozolomide in children with recurrent ependymoma: A case report
por: Zhao, Shuangshuang, et al.
Publicado: (2022)

Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells
por: Ohba, Shigeo, et al.
Publicado: (2021)

Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma
por: Shinsato, Yoshinari, et al.
Publicado: (2013)

Molecularly targeted treatment of recurrent anaplastic astrocytoma – a case report
por: Yalamanchi, Ashna, et al.
Publicado: (2021)

Temozolomide for the treatment of metastatic melanoma
por: Quirbt, I., et al.
Publicado: (2007)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Temozolomide – Just a Radiosensitizer?
por: Kaina, Bernd, et al.
Publicado: (2022)

Piperine synergistically enhances the effect of temozolomide against temozolomide-resistant human glioma cell lines
por: Jeong, Somi, et al.
Publicado: (2020)

Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: a retrospective analysis
por: Batara, Julette Marie F, et al.
Publicado: (2022)

The Role of Chemotherapy in Anaplastic Astrocytoma Patients
por: Kim, Sung Kwon, et al.
Publicado: (2012)

A rare brainstem anaplastic astrocytoma
por: You, Rongjiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nsffu1llgu2mqakap2sb4e8snb